FRAC 2024 POSTER PUBLISHED: INTRODUCTION OF TAVABOROLE ACTIVE INGREDIENT IN GROUP 54
March 2024, New poster is released by the Fungicide Resistance Action Committee (FRAC), revealing the inclusion of Group 54, Benzoxaboroles, in the…
March 2024, New poster is released by the Fungicide Resistance Action Committee (FRAC), revealing the inclusion of Group 54, Benzoxaboroles, in the…
Summary : Roche’s Vabysmo is having a strong start with doctors, but it has a long way to go if it wants…
KEYWORDS: Dunad Therapeutics, a biopharmaceutical company focusing on the development of next-generation targeted protein degradation therapies, announces that it has entered a strategic…
Keypoints USFDA approves Roche’s Tecentriq as adjuvant treatment for certain people with early NSCLC Tecentriq treatment reduced the risk of disease recurrence…